UBS Group AG - MIRAGEN THERAPEUTICS INC ownership

MIRAGEN THERAPEUTICS INC's ticker is MGEN and the CUSIP is 60463E103. A total of 58 filers reported holding MIRAGEN THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
UBS Group AG ownership history of MIRAGEN THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$0
-100.0%
200
-98.4%
0.00%
Q2 2020$13,000
+44.4%
12,123
-37.8%
0.00%
Q1 2020$9,00019,496
+9648.0%
0.00%
Q4 2019$02000.0%0.00%
Q3 2019$0200
-27.0%
0.00%
Q2 2019$0
-100.0%
274
+37.0%
0.00%
Q1 2019$1,000
-97.1%
200
-98.2%
0.00%
Q4 2018$34,000
-43.3%
11,144
+4.3%
0.00%
Q3 2018$60,000
+106.9%
10,684
+136.6%
0.00%
Q2 2018$29,000
+61.1%
4,516
+72.8%
0.00%
Q1 2018$18,000
-30.8%
2,613
+6.4%
0.00%
Q4 2017$26,000
+550.0%
2,455
+460.5%
0.00%
Q3 2017$4,000
-80.0%
438
-72.3%
0.00%
Q2 2017$20,0001,5820.00%
Other shareholders
MIRAGEN THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
SPHERA FUNDS MANAGEMENT LTD. 30,497$502,0000.04%
DRIEHAUS CAPITAL MANAGEMENT LLC 33,333$548,0000.01%
View complete list of MIRAGEN THERAPEUTICS INC shareholders